» Articles » PMID: 20501327

P2X and NMDA Receptor Involvement in Temporomandibular Joint-evoked Reflex Activity in Rat Jaw Muscles

Overview
Journal Brain Res
Specialty Neurology
Date 2010 May 27
PMID 20501327
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously shown that injection of the excitatory amino glutamate into the rat temporomandibular joint (TMJ) evokes reflex activity in both anterior digastric (DIG) and masseter (MASS) muscles that can be attenuated by prior TMJ injection of an N-methyl-d-aspartate (NMDA) receptor antagonist. The aim of the present study was to test if jaw muscle activity could also be evoked by P2X receptor agonist injection into the rat TMJ region and if the reflex activity could be modulated by TMJ injection of P2X receptor antagonist or NMDA receptor antagonist. The selective P2X subtype agonist alpha,beta-methylene adenosine 5'-triphosphate (alpha,beta-me ATP) and vehicle (phosphate-buffered saline) or the selective P2X antagonist, 2'-(or-3')-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP) or the selective NMDA antagonist (+/-)-d-2-amino-5-phosphonovalerate(APV) were injected into the rat TMJ region. Electromyographic (EMG) reflex activity was recorded in both DIG and MASS muscles. Compared with the baseline EMG activity, alpha,beta-me-ATP injection into the TMJ (but not its systemic administration) following pre-injection of the vehicle significantly increased the magnitude and the duration of ipsilateral DIG and MASS EMG activity in a dose-dependent manner. The alpha,beta-me-ATP-evoked responses could be antagonized by pre-injection of TNP-ATP into the same TMJ site but contralateral TMJ injection of TNP-ATP proved ineffective. Furthermore, the alpha,beta-me-ATP-evoked responses could also be antagonized by APV injected into the same TMJ site but not by its systemic injection. These results indicate the interaction of peripheral purinergic as well as glutamatergic receptor mechanisms in the processing of TMJ nociceptive afferent inputs that evoke reflex activity in jaw muscles.

Citing Articles

Preclinical orofacial pain assays and measures and chronic primary orofacial pain research: where we are and where we need to go.

Sadighparvar S, Al-Hamed F, Sharif-Naeini R, Meloto C Front Pain Res (Lausanne). 2023; 4:1150749.

PMID: 37293433 PMC: 10244561. DOI: 10.3389/fpain.2023.1150749.


Dura-evoked neck muscle activity involves purinergic and N-methyl-D-aspartate receptor mechanisms.

Yao D, Yoshida M, Sessle B Neuroreport. 2015; 26(18):1155-60.

PMID: 26559728 PMC: 4646704. DOI: 10.1097/WNR.0000000000000489.


Inflammation, pain, and pressure--purinergic signaling in oral tissues.

Lim J, Mitchell C J Dent Res. 2012; 91(12):1103-9.

PMID: 23042126 PMC: 3497906. DOI: 10.1177/0022034512463239.


Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Miller K, Hoffman E, Sutharshan M, Schechter R Pharmacol Ther. 2011; 130(3):283-309.

PMID: 21276816 PMC: 5937940. DOI: 10.1016/j.pharmthera.2011.01.005.

References
1.
Ambalavanar R, Moritani M, Dessem D . Trigeminal P2X3 receptor expression differs from dorsal root ganglion and is modulated by deep tissue inflammation. Pain. 2005; 117(3):280-291. DOI: 10.1016/j.pain.2005.06.029. View

2.
Ichikawa H, Fukunaga T, Jin H, Fujita M, Takano-Yamamoto T, Sugimoto T . VR1-, VRL-1- and P2X3 receptor-immunoreactive innervation of the rat temporomandibular joint. Brain Res. 2004; 1008(1):131-6. DOI: 10.1016/j.brainres.2004.02.029. View

3.
Gu J, Macdermott A . Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature. 1997; 389(6652):749-53. DOI: 10.1038/39639. View

4.
Macdermott A, Role L, Siegelbaum S . Presynaptic ionotropic receptors and the control of transmitter release. Annu Rev Neurosci. 1999; 22:443-85. DOI: 10.1146/annurev.neuro.22.1.443. View

5.
Petruska J, Cooper B, Gu J, Rau K, Johnson R . Distribution of P2X1, P2X2, and P2X3 receptor subunits in rat primary afferents: relation to population markers and specific cell types. J Chem Neuroanat. 2000; 20(2):141-62. DOI: 10.1016/s0891-0618(00)00080-6. View